Skip to main content
Premium Trial:

Request an Annual Quote

XDx s AlloMap and NimbleGen s Microbial Whole-Genome Resequencing Technology

Premium

XDx last week launched AlloMap, a molecular expression profiling test capable of predicting patient outcomes following heart transplantation, the company said in a statement. The test "has a high negative predictive value" for heart transplant rejection, guiding treatment with anti-rejection drugs and reducing problem biopsies, XDx said.


NimbleGen this week introduced its Microbial Whole-Genome Resequencing Technology, which "surveys an entire microbial genome to pinpoint genetic changes" to the SNP level, the company said in a statement.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.